论文部分内容阅读
目的应用小牛血去蛋白提取物注射液联合奥扎格雷钠治疗急性脑梗死,观察其疗效。方法选择2010年1月至2013年1月收治,发病在1周以内的脑梗死患者,随机分为舒血宁、小牛血蛋白提取物和奥扎格雷钠联合治疗组(治疗组,80例)和单用舒血宁组(对照组,80例)。两组均常规给予综合治疗。比较两组的治疗效果。结果治疗组总有效率为91.25%,对照组为58.75%,治疗组总有效率明显高于对照组(P<0.05)。两组均未见明显不良反应。结论舒血宁注射液、奥扎格雷钠和小牛血去蛋白提取物注射液联合应用治疗急性脑梗死优于单纯舒血宁注射液。
Objective To observe the therapeutic effect of deproteinized calf blood extract and ozagrel sodium on acute cerebral infarction. Methods Patients with cerebral infarction who were admitted to our hospital from January 2010 to January 2013 and whose incidence was within 1 week were randomly divided into Shuxuening, Bovine Serum Protein Extract and Ozagrel Sodium combined treatment group (treatment group, 80 cases ) And Shuxuening alone group (control group, 80 cases). Both groups were routinely given comprehensive treatment. Compare the treatment effect of two groups. Results The total effective rate was 91.25% in the treatment group and 58.75% in the control group. The total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). No obvious adverse reactions were found in both groups. Conclusion Shuxuening injection, ozagrel sodium and deproteinized extract of calf blood are better than simple Shuxuening injection in treating acute cerebral infarction.